Emerald Mutual Fund Advisers Trust Blueprint Medicines Corp Transaction History

Emerald Mutual Fund Advisers Trust

$1.77 Billion
Q3 2024

A detailed history of Emerald Mutual Fund Advisers Trust transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 288,540 shares of BPMC stock, worth $25.6 Million. This represents 1.51% of its overall portfolio holdings.

Number of Shares

288,540

Previous 278,333 3.67%

Holding current value

$25.6 Million

Previous $30 Million 11.07%

% of portfolio

1.51%

Previous 1.71%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$84.1 - $120.5 $858,408 - $1.23 Million	10,207 Added 3.67%	288,540 $26.7 Million
Q2 2024 Aug 06, 2024	SELL	$85.18 - $108.78 $3.19 Million - $4.08 Million	-37,486 Reduced 11.87%	278,333 $30 Million
Q1 2024 May 08, 2024	SELL	$73.17 - $99.79 $4.72 Million - $6.43 Million	-64,441 Reduced 16.95%	315,819 $30 Million
Q4 2023 Feb 05, 2024	SELL	$43.96 - $92.84 $3.7 Million - $7.8 Million	-84,061 Reduced 18.1%	380,260 $35.1 Million
Q3 2023 Oct 26, 2023	BUY	$46.9 - $66.0 $2.39 Million - $3.37 Million	50,994 Added 12.34%	464,321 $23.3 Million
Q2 2023 Aug 10, 2023	BUY	$42.2 - $66.37 $2.3 Million - $3.62 Million	54,507 Added 15.19%	413,327 $26.1 Million
Q1 2023 May 04, 2023	BUY	$37.97 - $50.0 $2.02 Million - $2.66 Million	53,111 Added 17.37%	358,820 $16.1 Million
Q4 2022 Feb 03, 2023	BUY	$41.06 - $66.48 $2.14 Million - $3.46 Million	52,064 Added 20.53%	305,709 $13.4 Million
Q3 2022 Oct 25, 2022	BUY	$49.93 - $77.7 $12.7 Million - $19.7 Million	253,645 New	253,645 $16.7 Million
Q1 2022 Apr 29, 2022	SELL	$54.1 - $110.08 $12 Million - $24.5 Million	-222,217 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$94.25 - $115.99 $2.2 Million - $2.71 Million	-23,340 Reduced 9.5%	222,217 $23.8 Million
Q2 2021 Jul 29, 2021	SELL	$82.78 - $101.0 $2.77 Million - $3.38 Million	-33,429 Reduced 11.98%	245,557 $21.6 Million
Q1 2021 Apr 29, 2021	SELL	$90.71 - $108.28 $249,724 - $298,094	-2,753 Reduced 0.98%	278,986 $27.1 Million
Q4 2020 Jan 29, 2021	SELL	$92.08 - $124.48 $7.61 Million - $10.3 Million	-82,634 Reduced 22.68%	281,739 $31.6 Million
Q3 2020 Oct 28, 2020	BUY	$66.45 - $92.7 $469,867 - $655,481	7,071 Added 1.98%	364,373 $33.8 Million
Q2 2020 Jul 28, 2020	SELL	$57.09 - $79.27 $369,372 - $512,876	-6,470 Reduced 1.78%	357,302 $27.9 Million
Q1 2020 Apr 30, 2020	BUY	$48.11 - $82.22 $17.5 Million - $29.9 Million	363,772 New	363,772 $21.3 Million

Others Institutions Holding BPMC

# of Institutions

350

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.3B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.

Account

Emerald Mutual Fund Advisers Trust Blueprint Medicines Corp Transaction History